Impact of prior bariatric surgery on risk and severity of COVID-19 infection: A meta-analysis of observational studies

Hung, Kuo‐Chuan; Chen, Hsiao-Tien; Hsing, Chung-Hsi; Jinn-Rung, Kuo; Ho, Cheng-Mao; Lin, Yuan‐Yung; Chang, Ying-Jen; Chiu, Sheng‐Fu; Sun, Cheuk‐Kwan

doi:10.1016/j.orcp.2022.10.005

Cited by 8 publications

(7 citation statements)

References 50 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Likewise, the results of a study by Valera et al ( 27 ) suggest that the risk of hospitalization due to influenza may fall after bariatric surgery. In turn, in relation to meta-analysis of observational studies it seems that obesity surgery is related to less severe COVID-19 ( 28 ). To assess the influence of bariatric surgery on the risk of infectious diseases, additional, randomized controlled trials are needed.…”

Section: Discussionmentioning

confidence: 99%

Comparison of pre-and postoperative medication costs in patients who underwent bariatric surgery – a nationwide data analysis

Osińska,

Sanchak,

Śliwczyński

et al. 2024

Front. Public Health

View full text Add to dashboard Cite

IntroductionBariatric surgery has known health benefits and may lower the medication-related costs. This study aimed to assess the cost of medications prior to and after bariatric surgery in the Polish nationwide registry.MethodsThe study included 2,390 adults. The analysis was conducted separately for a 12-month pre-operative period, and a 12-month postoperative period. The total costs of medication and cost per anatomical therapeutic chemical group were assessed and the mean cost per patient in the preoperative and postoperative periods was compared.ResultsThe study showed a significant increase in the overall medication costs and mean costs of medications per patient in the year after bariatric surgery. This increase was related mainly to low-molecular-weight heparins used in the 1st month after surgery. Alternatively, costs of medication used in the cardiovascular system diseases and anti-infectives decreased significantly. The total costs of hypoglycemic agents were reduced by 46%, antihypertensive medications by 29%, and lipid-lowering drugs by 38.ConclusionsIn general, medication costs are higher in the first year after surgery. The increase results from the perioperative use of low-molecular-weight heparins, whereas a significant cost reduction of glucose-, lipid-lowering, antihypertensive, and anti-infective medications was observed.

show abstract

Section: Discussionmentioning

confidence: 99%

Comparison of pre-and postoperative medication costs in patients who underwent bariatric surgery – a nationwide data analysis

Osińska,

Sanchak,

Śliwczyński

et al. 2024

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…Test positivity rates were similar between the two groups; however, MBS was associated with significantly lower need for hospital admission and supplemental oxygen and less severe disease course of covid-19 92. Three systematic reviews and meta-analyses have also been published 939495. The largest of these included nine articles and 1 130 341 people.…”

Section: Obesity and Metabolic/bariatric Surgery In The Era Of Covid-19mentioning

confidence: 96%

“…As the pandemic evolved, observational data began to suggest a protective effect of previous MBS in people with covid-19 9192939495. A retrospective cohort study compared patients with obesity admitted with covid-19 who had had previous MBS (n=2607) versus those who had not (n=122 092).…”

Section: Obesity and Metabolic/bariatric Surgery In The Era Of Covid-19mentioning

confidence: 99%

Long term outcomes of metabolic/bariatric surgery in adults

Courcoulas,

Daigle,

Arterburn

2023

BMJ

View full text Add to dashboard Cite

The prevalence of obesity continues to rise around the world, driving up the need for effective and durable treatments. The field of metabolic/bariatric surgery has grown rapidly in the past 25 years, with observational studies and randomized controlled trials investigating a broad range of long term outcomes. Metabolic/bariatric surgery results in durable and significant weight loss and improvements in comorbid conditions, including type 2 diabetes. Observational studies show that metabolic/bariatric surgery is associated with a lower incidence of cardiovascular events, cancer, and death. Weight regain is a risk in a fraction of patients, and an association exists between metabolic/bariatric surgery and an increased risk of developing substance and alcohol use disorders, suicidal ideation/attempts, and accidental death. Patients need lifelong follow-up to help to reduce the risk of these complications and other nutritional deficiencies. Different surgical procedures have important differences in risks and benefits, and a clear need exists for more long term research about less invasive and emerging procedures. Recent guidelines for the treatment of obesity and metabolic conditions have been updated to reflect this growth in knowledge, with an expansion of eligibility criteria, particularly people with type 2 diabetes and a body mass index between 30.0 and 34.9.

show abstract

“…People who had undergone bariatric surgery in the past had lower risk of severe disease, ICU admission and mortality compared to obese adults who had not [26] . In fact, they had lower BMI and lower prevalence of diabetes.…”

Section: Metabolic Syndrome As a Risk Factor For Adverse Covid-19 Out...mentioning

confidence: 96%

COVID-19 and metabolic syndrome

Dissanayake

2023

Best Practice & Research Clinical Endocrinology & Metab

View full text Add to dashboard Cite

Impact of prior bariatric surgery on risk and severity of COVID-19 infection: A meta-analysis of observational studies

Cited by 8 publications

References 50 publications

Comparison of pre-and postoperative medication costs in patients who underwent bariatric surgery – a nationwide data analysis

Comparison of pre-and postoperative medication costs in patients who underwent bariatric surgery – a nationwide data analysis

Long term outcomes of metabolic/bariatric surgery in adults

COVID-19 and metabolic syndrome

Contact Info

Product

Resources

About